Latest news
Alebund’s AP301 NDA Accepted for Review by China’s NMPA - Macau BusinessMacau Business · Sat, 08 Aug 2026 09:07:49 GMTPolyPid's Double Win: D-PLEX₁₀₀ Gains NDA Acceptance and Priority Review, Ahead of Schedule (NASDAQ: PYPD - BenzingaBenzinga · Fri, 31 Jul 2026 15:28:54 GMTBridgeBio Pharma (BBIO) Wins FDA NDA Acceptance, Is The Upside Already Priced In? - simplywall.stsimplywall.st · Fri, 31 Jul 2026 05:37:39 GMTPolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀ - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 12:30:00 GMTFDA Acceptance Triggers $15M Payment to PolyPid Under Partnership - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT